Jefferies Financial Group’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-65,300
Closed -$525K 1884
2024
Q4
$525K Hold
65,300
﹤0.01% 1086
2024
Q3
$825K Sell
65,300
-6,600
-9% -$85.2K 0.01% 835
2024
Q2
$910K Buy
71,900
+6,600
+10% +$66.4K 0.01% 783
2024
Q1
$312K Buy
65,300
+9,000
+16% +$41.7K ﹤0.01% 1202
2023
Q4
$270K Buy
+56,300
New +$345K ﹤0.01% 1395
2023
Q1
Sell
-22,400
Closed -$230K 1876
2022
Q4
$230K Buy
+22,400
New +$395K ﹤0.01% 1264

Other funds holding NVAX

Jefferies Financial Group's NVAX Position: Q1 2026 in Review

Jefferies Financial Group opened a new position in Novavax (NVAX) in Q1 2026: 673,120 shares worth $5.48M. The stake represents 0.04% of the portfolio and ranks #327 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in NVAX as recently as Q4 2024.

Jefferies Financial Group first reported a position in NVAX in Q4 2022 and has held it in 8 quarters since. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Jefferies Financial Group held 673,120 shares of Novavax worth $5.48M as of Q1 2026.
  • Novavax was a new Jefferies Financial Group position in Q1 2026.
  • Novavax made up 0.04% of Jefferies Financial Group's portfolio in Q1 2026, its #327 holding.
  • Jefferies Financial Group first reported a position in Novavax in Q4 2022 and has held it in 8 quarters since.
  • 258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.